| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* The Edward Jenner Institute for Vaccine Research, Compton, United Kingdom;
Department of Immunology, Paul Ehrlich Institute, Langen, Germany; and
Department of Immunology and Cell Biology, Research Center Borstel, Borstel, Germany
Type I IFN (IFN-
), which is produced rapidly in response to infection, plays a key role in innate immunity and also acts as a stimulus for the adaptive immune response. We have investigated how IFN- induces cross-priming, comparing CD8+ T cell responses generated against soluble protein Ags in the presence or absence of IFN-. Injection of IFN- was found to prolong the proliferation and expansion of Ag-specific CD8+ T cells, which was associated with marked up-regulation of IL-2 and IL-15 receptors on Ag-specific cells and expression of IL-15 in the draining lymph node. Surprisingly, neither IL-2 nor IL-15 was required for IFN--induced cross-priming. Conversely, expression of the IFN-R by T cells was shown to be necessary for effective stimulation of the response by IFN-. The finding that T cells represent direct targets of IFN--mediated stimulation reveals an additional mechanism by which the innate response to infection promotes adaptive immunity.
This article has been cited by other articles:
|
|
 |
|
  H. Agrawal, N. Jacob, E. Carreras, S. Bajana, C. Putterman, S. Turner, B. Neas, A. Mathian, M. N. Koss, W. Stohl, et al. Deficiency of Type I IFN Receptor in Lupus-Prone New Zealand Mixed 2328 Mice Decreases Dendritic Cell Numbers and Activation and Protects from Disease J. Immunol., November 1, 2009; 183(9): 6021 - 6029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. McGill, J. W. Heusel, and K. L. Legge Innate immune control and regulation of influenza virus infections J. Leukoc. Biol., October 1, 2009; 86(4): 803 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Zietara, M. Lyszkiewicz, N. Gekara, J. Puchalka, V. A. P. M. Dos Santos, C. R. Hunt, T. K. Pandita, S. Lienenklaus, and S. Weiss Absence of IFN-{beta} Impairs Antigen Presentation Capacity of Splenic Dendritic Cells via Down-Regulation of Heat Shock Protein 70 J. Immunol., July 15, 2009; 183(2): 1099 - 1109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Longhi, C. Trumpfheller, J. Idoyaga, M. Caskey, I. Matos, C. Kluger, A. M. Salazar, M. Colonna, and R. M. Steinman Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant J. Exp. Med., July 6, 2009; 206(7): 1589 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Sikora, N. Jaffarzad, Y. Hailemichael, A. Gelbard, S. W. Stonier, K. S. Schluns, L. Frasca, Y. Lou, C. Liu, H. A. Andersson, et al. IFN-{alpha} Enhances Peptide Vaccine-Induced CD8+ T Cell Numbers, Effector Function, and Antitumor Activity J. Immunol., June 15, 2009; 182(12): 7398 - 7407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. N. Lee, S. Burke, M. Montoya, and P. Borrow Multiple Mechanisms Contribute to Impairment of Type 1 Interferon Production during Chronic Lymphocytic Choriomeningitis Virus Infection of Mice J. Immunol., June 1, 2009; 182(11): 7178 - 7189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Broomfield, R. G. van der Most, A. C. Prosser, S. Mahendran, M. G. Tovey, M. J. Smyth, B. W. S. Robinson, and A. J. Currie Locally Administered TLR7 Agonists Drive Systemic Antitumor Immune Responses That Are Enhanced by Anti-CD40 Immunotherapy J. Immunol., May 1, 2009; 182(9): 5217 - 5224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ahmed, L. M. Mitchell, S. Puckett, K. L. Brzoza-Lewis, D. S. Lyles, and E. M. Hiltbold Vesicular Stomatitis Virus M Protein Mutant Stimulates Maturation of Toll-Like Receptor 7 (TLR7)-Positive Dendritic Cells through TLR-Dependent and -Independent Mechanisms J. Virol., April 1, 2009; 83(7): 2962 - 2975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cervantes-Barragan, U. Kalinke, R. Zust, M. Konig, B. Reizis, C. Lopez-Macias, V. Thiel, and B. Ludewig Type I IFN-Mediated Protection of Macrophages and Dendritic Cells Secures Control of Murine Coronavirus Infection J. Immunol., January 15, 2009; 182(2): 1099 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Currie, R. G. van der Most, S. A. Broomfield, A. C. Prosser, M. G. Tovey, and B. W. S. Robinson Targeting the Effector Site with IFN-{alpha}{beta}-Inducing TLR Ligands Reactivates Tumor-Resident CD8 T Cell Responses to Eradicate Established Solid Tumors J. Immunol., February 1, 2008; 180(3): 1535 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Randall and S. Goodbourn Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures J. Gen. Virol., January 1, 2008; 89(1): 1 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Arakura, S. Hida, E. Ichikawa, C. Yajima, S. Nakajima, T. Saida, and S. Taki Genetic Control Directed toward Spontaneous IFN-{alpha}/IFN-beta Responses and Downstream IFN-{gamma} Expression Influences the Pathogenesis of a Murine Psoriasis-Like Skin Disease J. Immunol., September 1, 2007; 179(5): 3249 - 3257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hervas-Stubbs, A. Olivier, F. Boisgerault, N. Thieblemont, and C. Leclerc TLR3 ligand stimulates fully functional memory CD8+ T cells in the absence of CD4+ T-cell help Blood, June 15, 2007; 109(12): 5318 - 5326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Curtsinger, M. Y. Gerner, D. C. Lins, and M. F. Mescher Signal 3 Availability Limits the CD8 T Cell Response to a Solid Tumor J. Immunol., June 1, 2007; 178(11): 6752 - 6760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bach, E. Kamphuis, B. Odermatt, G. Sutter, C. J. Buchholz, and U. Kalinke Vesicular Stomatitis Virus Glycoprotein Displaying Retrovirus-Like Particles Induce a Type I IFN Receptor-Dependent Switch to Neutralizing IgG Antibodies J. Immunol., May 1, 2007; 178(9): 5839 - 5847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Douagi, G. M. McInerney, A. S. Hidmark, V. Miriallis, K. Johansen, L. Svensson, and G. B. Karlsson Hedestam Role of Interferon Regulatory Factor 3 in Type I Interferon Responses in Rotavirus-Infected Dendritic Cells and Fibroblasts J. Virol., March 15, 2007; 81(6): 2758 - 2768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hervas-Stubbs, P. Rueda, L. Lopez, and C. Leclerc Insect Baculoviruses Strongly Potentiate Adaptive Immune Responses by Inducing Type I IFN J. Immunol., February 15, 2007; 178(4): 2361 - 2369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Longman, D. Braun, S. Pellegrini, C. M. Rice, R. B. Darnell, and M. L. Albert Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-{alpha}/{beta} on antigen cross-presentation Blood, February 1, 2007; 109(3): 1113 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hosmalin and P. Lebon Type I interferon production in HIV-infected patients J. Leukoc. Biol., November 1, 2006; 80(5): 984 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. McBride, K. Hoebe, P. Georgel, and E. Janssen Cell-Associated Double-Stranded RNA Enhances Antitumor Activity through the Production of Type I IFN J. Immunol., November 1, 2006; 177(9): 6122 - 6128. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
